OH-EBASHI and HANLING China Legal Newsletter 2022 March Issue was published.

****************************************************************************************************

1.　A Few Key Points of the China Personal Information Protection Law By Yuchuan Sun (Hanling & Partners）
Protection of personal information was not a novel topic in China but was regulated and addressed separately by a few different laws, regulations and national standards. However, different regulations focus on different aspects of this area. For example, the Cybersecurity Law regulates the processing of personal information mainly from the perspective of data security while the Civil Code protects personal information as a part of natural person's "right to privacy". Such a scheme has left a fragmented implementation of the regulation mechanism to the protection of personal information. As response to such a situation, adopted on 20 August 2021 and came into force as of 1 November 2021, the longwaited Personal Information Protection Law ("PIPL"), for the first time, lays down a coherent and comprehensive framework which marked a new era in the area of personal information protection. In stead of go over the whole PIPL provision by provision, this article will provide the readers with an insight to some of the most important points of the PIPL. ...(Please click here to read more.）

2.　A Legal Review of China's Life Sciences and Healthcare- No.1 －General Introduction and MAH System
　　By Fumi Takatsuki (Oh-Ebashi & Partners LPC) and Yuchuan Sun (Hanling & Partners）
I. The Life Science and Healthcare Industries in PRC
Supported by the improvement of general life quality and strong need for high quality medical and healthcare services, recently, the life science and healthcare industries have been two of the most fast-expanding industries in China. According to the outline of the "Healthy China 2030 Plan" released by the Chinese government in October 2016, the market size of the medical and health care industry in PRC was expected to reach RMB 8 trillion by the end of 2020 and RMB 16 trillion by the end of 2030.
Although hit by the unexpected pandemic of Covid-19 at the beginning of 2020, we still witnessed a strong growth in China's healthcare market in the recent two years.
According to a report released by the China Internet Association in July 2021, the overall market size of the healthcare market is likely to reach RMB 7.4 trillion at the end of 2021 and is estimated to reach RMB 17.6 trillion by 2030, making it an important market for all participants to the global healthcare related industries including drug, medical device, cosmetics, health food, and health information service. .....(Please click here to read more.）